Archives: Speakers

Bryan brings over nine years of experience in clinical trial support, having held diverse roles at Emsere in logistics, equipment preparation and testing, project management, and business development. His multifaceted career has provided him with a comprehensive understanding of the clinical trial landscape, including the numerous factors and touchpoints that can influence trial success. Bryan’s cross-departmental expertise enables him to identify potential challenges, anticipate real-world implications of decisions, and provide actionable insights to ensure smoother trial operations.

Jon is a seasoned professional with over 20 years of experience and has demonstrated expertise in helping Pharma, Biotech and CROs solve complex and challenging development issues; ensuring clinical studies remain on their critical path to success.

Throughout his tenured career, Jon has held pivotal roles at Pfizer and Avantor where he has made significant contributions to the development and launch of life saving and life changing medicines and he now brings that expertise to Emsere. As a speaker, Jon engages audiences with insightful discussions, drawing from his extensive experience and unique perspectives.

Joining the company in 2012, Saki has gained extensive experience in Logistics, Administration, and International Business Operations. Since 2018, she has been actively involved in the probiotics/postbiotic field. She successfully promoted probiotics and postbiotics business in the EMEA region when she was appointed as a Commercial Manager in Germany for nearly 4 years. Currently, she is based in the headquarters in Tokyo and is passionate about utilizing her previous learnings and skills to further support Morinaga Milk’s Probiotics/Postbiotic global business expansion through marketing activities.​ 

Analyst in the market research industry with a focus on biopharmaceutical dealmaking activity, with expertise in managing and maintaining databases pertaining to company attributes, deals and news to deliver value to stakeholders. Alison’s background also includes competitive intelligence in oncology and cardiovascular indications, as well as experience in a COVID-19 diagnostics lab. She also holds an MSc in Reproductive and Developmental Medicine, as well as a BSc in Biomedical Science – both from the University of Sheffield.

Laura is a perceptive, versatile, results-oriented and proven clinical operations leader with a passion for patient and site experience, access to healthcare, and co-creating the future of clinical research. Leveraging deep experience in study delivery, people leadership and development, and data-driven insights, she believes that the cores of leadership are curiosity and service.

Dr. Peter Schmidt is a neuroscientist with a wealth of experience in biomedical research. He’s been an inventor, principal investigator, and mathematician with experience in neurology, psychiatry, and immunology. Before joining Rho, he was the Vice Dean at East Carolina University’s Brody School of Medicine, where he oversaw research and clinical care. During his time at the Parkinson’s Foundation, Dr. Schmidt designed and led the largest clinical study of Parkinson’s disease, enrolling 12,000 patients across 30 academic medical centers in five countries. He has served in advisory and board roles for national and international organizations in clinical care, research, and patient advocacy including the National Quality Forum, the Cystic Fibrosis Foundation, and the Huntington’s Study Group. He holds two patents and has authored many peer-reviewed journal articles.

Dr. Andrew Feigin is a neurologist with over 30 years of experience. Throughout his career, he’s made groundbreaking contributions to neurology and clinical research. After a fellowship in experimental therapeutics, Dr. Feigin joined North Shore University Hospital as an assistant professor of neurology. There, he set up a clinical trial program for Parkinson’s, Huntington’s, Tourette syndrome, dystonia and other movement disorders. Subsequently, Dr. Feigin joined the NYU Grossman School of Medicine as Professor of Neurology where he directed the Fresco Institute for Parkinson’s and Movement Disorders. He’s been the site principal investigator for over 30 clinical trials, and a global PI for several multicenter clinical trials including the first phase 1 gene therapy trial for Parkinson’s and several large multicenter trials for Huntington’s disease. Dr. Feigin has pursued independent research developing imaging biomarkers for neurodegenerative disorders, and he has published over 150 peer-reviewed articles. He’s a member of prestigious organizations including the American Academy of Neurology, the American Neurological Association, and the Movement Disorder Society, and he has served on numerous advisory boards, steering committees, DSMB’s, and NIH and foundation review committees.

Chris is a RTSM Solutions Specialist at Medidata with over 25 years of experience in Clinical Research specialising in Randomisation and Trial Supply Management (RTSM). He began his career at Clinphone working as a programmer and has held various Technical and Project related roles at Technology Vendors and CROs. With his vast experience and knowledge, he has a great understanding of what it takes to efficiently work with Sponsors and to help them select and develop systems. Chris is a graduate of Nottingham Trent University and holds a Bachelors of Science degree in Physics and Computer Science.